No single blood test confirms perimenopause, and your period calendar comes closer

Key takeaways

• In a U.S. study of more than 1,300 women in their 40s and early 50s, 91% had one to three bouts of bleeding lasting 10 days or more within three years⁵.
• Perimenopause lasts about four years on average and can last up to 10, according to the federal Office on Women’s Health¹.
• England’s NICE guideline says women over 45 with typical symptoms can be diagnosed without lab tests, and it advises against estradiol and AMH tests for that job¹⁰.
• Pregnancy is still possible: a British guideline says women aged 40 to 50 using non-hormonal birth control can stop after two years without a period, and women over 50 after one year¹¹.
• In a snapshot of 1,000 Instagram menopause posts, 661 promoted supplements, and fewer than 1 in 5 of those came from clinicians¹⁴.

Starting in 1996, more than 1,300 women in southeast Michigan and California kept a running record of the days they bled. They were 42 to 52 years old and part of the Study of Women’s Health Across the Nation, or SWAN, a long-running study of midlife women funded by the National Institutes of Health⁵.

The researchers reported what those records showed in 2014, in the journal BJOG. Within a three-year window, 91% of the women had one to three bouts of bleeding that lasted 10 days or longer⁵. Nearly 88% had six or more days of spotting, and close to 78% had three or more days of heavy flow⁵.

“For most women in their 30s, menstrual periods are highly predictable,” said Siobán Harlow, a University of Michigan researcher on the team⁵. Once the transition starts in the 40s, she said, periods can change a lot, and women often wonder whether something is wrong⁵.

Usually, what’s happening has a name: perimenopause, the years-long run-up to the final period. No single blood test confirms it¹¹⁰. Your calendar is a better guide.

The transition has also become a marketing target, especially for supplements¹⁴¹⁵. Below, we cover what the stages look like, which symptoms are common, why tests mislead, why birth control still matters and when to get care.

Your cycle, not your birthday, marks the stages

In 2011, an international group of scientists met to update a staging system for reproductive aging, known as STRAW+10³. It sorts the years around the last period by what your cycle does. The authors recommend it regardless of age, ethnicity, body size or lifestyle³.

• Early transition. Cycle lengths start to differ by 7 days or more from one cycle to the next, and the change persists⁴.
• Late transition. You go 60 days or more without a period. This stage usually lasts one to three years, and hot flashes become likely⁴.
• Menopause. It’s confirmed only in hindsight, once a full year passes with no bleeding or spotting at all¹.

Perimenopause usually begins in the mid- to late 40s, though some women notice changes in their mid- to late 30s¹. The Office on Women’s Health (OWH), part of the U.S. Department of Health and Human Services, says it lasts about four years on average and can last up to 10¹.

Experts count those years differently. The Menopause Society, a professional group of menopause clinicians, puts the average closer to six years⁶. Either way, plan for a span of years, not months.

The National Institute on Aging calls menopause a normal part of aging, not a disease or disorder². Many natural-health readers already see it that way. Normal doesn’t mean you must put up with symptoms that wreck your sleep or your work, though.

Women know about hot flashes, and fatigue tops their lists

In January 2026, the journal Menopause published a survey of more than 17,000 women in 158 countries, recruited through Flo, a commercial period-tracking app⁶. The news release didn’t say who paid for the analysis, and app users aren’t a random sample.

Asked which symptoms belong to perimenopause, women most often named hot flashes (71%), sleep problems (68%) and weight gain (65%)⁶. But among the 12,681 women aged 35 and older, the symptoms reported most were fatigue and physical and mental exhaustion (83% each), irritability (80%) and depressed mood (77%)⁶.

OWH’s list is broad, too: hot flashes, night sweats, poor sleep, brain fog, mood changes, vaginal and bladder changes, shifts in desire, and joint and muscle pain⁷. Aches are more common than many women expect. When researchers pooled 37 studies, 57 in 100 women in perimenopause reported sore joints or muscles, versus 40 in 100 before the transition began⁷. By our math, that’s about 17 more women in every 100.

Periods change, too. OWH calls irregular periods normal in perimenopause, and it notes that shifting hormones can bring longer, heavier periods¹². In the SWAN calendars, fibroids, hormone use and body size all shaped how women bled⁵.

For brain fog, our companion article on menopause covers what SWAN found about memory over time. Tiredness and aches have many possible causes, and OWH advises telling your provider about new or worsening pain⁷.

Mood can shift, even with no history of depression

In 2018, The Menopause Society, then called the North American Menopause Society, and the National Network of Depression Centers published guidelines on depression during perimenopause, filling what the panel called a gap in clinical advice⁸. Their review found elevated depressive symptoms in 45% to 68% of women in perimenopause, versus 28% to 31% of women who hadn’t yet reached it⁸.

In SWAN, women were two to four times more likely to have an episode of major depression during the transition, mainly those who had been depressed before⁸. A past episode is the strongest predictor: 59% of women with a history of major depression had it again in midlife, compared with 28% of women without that history⁸. But the panel said the risk of depressive symptoms rises even in women who have never been depressed⁸.

Other risk factors included hot flashes, poor sleep, money trouble, stressful life events, little social support, and past premenstrual or postpartum depression⁸.

The guidelines name antidepressants and talk therapy, including cognitive behavioral therapy (CBT), as first-line treatment for major depression in perimenopause⁸. CBT is a structured, skills-based therapy. NICE, England’s health guidance agency, also suggests considering CBT for low mood or anxiety tied to menopause¹⁰.

Estrogen showed some antidepressant effect in women in perimenopause, but only in small trials, and it isn’t FDA-approved for mood⁸. It didn’t help depression after menopause⁸. Hormonal birth control may ease depressive symptoms as menopause nears, though it hasn’t been tested in trials of women with clinical depression⁸. The panel found too little evidence to recommend herbal or other alternative treatments for perimenopausal depression⁸.

If you have thoughts of harming yourself, call or text the 988 Suicide & Crisis Lifeline, any time⁷.

A hormone test is a snapshot of a moving target

Hormones don’t fade in a straight line during perimenopause. In the early transition, follicle-stimulating hormone (FSH), a pituitary hormone that rises as the ovaries slow, runs high but varies⁴. So one reading may not match the next.

That’s why NICE’s menopause guideline, updated in 2024, says to diagnose perimenopause without lab tests in otherwise healthy women over 45 who have hot flashes and irregular periods¹⁰. For that group, it advises against estradiol, anti-Müllerian hormone (AMH) and similar tests¹⁰. It keeps FSH testing mainly for women 40 to 45 with symptoms, or younger women when menopause is suspected¹⁰.

OWH agrees that blood tests usually aren’t needed and suggests tracking your periods and symptoms instead¹.

When a test matters, it’s usually because periods stop early. If yours stop before 40, OWH says to ask about testing¹. Our companion article on menopause explains why early menopause deserves attention, and a later article in this series covers at-home hormone tests. Our article on how hormones work explains why one test can mislead.

Pregnancy is less likely in your 40s, not impossible

Pregnancy is still possible in perimenopause, even when periods skip months¹. The Faculty of Sexual and Reproductive Healthcare (FSRH), a British clinical body, estimates that a year of unprotected sex leads to pregnancy in roughly 10% to 20% of women aged 40 to 44 and about 12% at 45 to 49¹¹.

These pregnancies carry more risk: the FSRH puts miscarriage at more than 50% for women over 45¹¹. It also reports that in England and Wales in 2015, 28.1% of recorded pregnancies in women 40 and older ended in abortion¹¹.

U.S. guidance is less precise. The CDC’s 2024 contraception recommendations say women over 44 who want to avoid pregnancy still need protection, because pregnancies, though uncommon, still happen⁹. No lab test can confirm that fertility has ended, the CDC adds. It cites ACOG and the North American Menopause Society (now The Menopause Society), which advise using birth control until menopause or age 50 to 55⁹.

The British FSRH guideline, first issued in 2017 and amended in 2025, spells out when birth control can end¹¹:

Your situation	What the British guideline says
Non-hormonal method, aged 40 to 50	Contraception can end after 2 years with no period
Non-hormonal method, over 50	Contraception can end after 1 year with no period
Combined pill, patch or ring	Can continue to 50, then switch methods
Implant, progestogen-only pill or hormonal IUD	Can continue to 55 (for a hormonal IUD, if fitted at 45 or older); an FSH test may help after 50
Anyone	Contraception can end at 55

Two cautions apply. Hormone levels measured while you use combined birth control or hormone therapy don’t show where you are in the transition¹¹. And menopause hormone therapy isn’t birth control¹¹. Ask your clinician how these rules fit your method and history.

Hormonal and hormone-free help both exist

Treatment depends on which symptom bothers you most, and some options do double duty.

• Combined pill, patch or ring. The FSRH says there’s some evidence it eases hot flashes in perimenopause, and it may reduce period pain and help bone density, while preventing pregnancy¹¹. Eligible women can use it until 50¹¹.
• Hormonal IUD. In Britain, 52 mg levonorgestrel IUDs are licensed to treat heavy periods¹¹. The same device can also serve as the progestogen part of hormone therapy for up to five years¹¹.
• Hormone therapy. The FDA has approved it to reduce moderate to severe hot flashes, prevent bone loss and relieve vaginal dryness¹³. Its risks vary with your age and health history, and with the kind of hormone, the dose and how it’s taken¹³.
• Hormone-free options. Three nonhormonal prescription drugs are FDA-approved for moderate to severe hot flashes, and CBT and clinical hypnosis can make hot flashes less bothersome¹³.

Daily habits help, too. OWH advises staying active, keeping a regular sleep routine and not smoking, but says healthy habits aren’t a substitute for treatment when symptoms disrupt your life¹³. Later articles in this series cover hot flashes and hormone therapy in depth, and our menopause sleep article covers nights.

Perimenopause became a sales category

In June 2024, two researchers at Walter Reed National Military Medical Center and the Uniformed Services University reviewed the top 100 Instagram posts under each of 10 menopause hashtags¹⁴. Of 1,000 posts, 661 promoted a branded supplement. Under #menopause alone, 90% did¹⁴.

More than half of the supplement posts came from people without clinical credentials, including influencers and self-described homeopaths. Businesses posted 30.4%, and credentialed clinicians 18.3%¹⁴.

Of the 20 most-advertised products, 9 used proprietary blends that hide ingredient amounts¹⁴. The 20 products averaged $43.49 a month¹⁴. By our math, that’s about $520 a year.

A University College London team found a similar picture in Britain. Its 2026 review of 201 menopause supplements, sold through nine major retailers and online outlets, found no ingredient common to all of them, widely varying doses, and prices from £1.50 to £95 a month¹⁵. The researchers found little evidence that the products work, even the priciest¹⁵. They flagged black cohosh, which was in 6 of the 20 Instagram products, for a possible risk of liver injury¹⁴¹⁵.

If you distrust drug-company marketing, give supplement and wellness marketing the same hard look. Our article on hormone-balancing claims covers saliva tests and custom-compounded hormones.

The perimenopause symptom log and decoder

OWH suggests tracking your periods and symptoms and sharing them with your provider¹. Each day for two or three months, jot down: bleeding (days, heaviness, pads or tampons used), hot flashes or night sweats, hours slept, mood from 1 to 5, aches, and energy. Then use this decoder, our own design built from the sources cited.

Symptom	Possible causes	What may help	When to call
Irregular, skipped or closer-together periods	The transition itself412; pregnancy is still possible1	Keep logging; a pregnancy test if you could be pregnant	If periods stop before 401
Longer or heavier periods	Hormone swings; fibroids and hormone use also play a part512	Hormonal IUD or other treatments11	Bleeding much heavier or longer than your normal, or large clots; our reproductive-symptoms guide lists the cutoffs12
Bleeding after sex or between periods	Several causes that need an exam	A visit, not home care	Bleeding after sex more than once, or spotting between periods12
Dizziness, weakness, chest pain or breathlessness around your period	Possible anemia from blood loss12	Medical care	Promptly; for an emergency, call 911112
Hot flashes and night sweats	The transition, especially its late stage4	CBT, hypnosis, hormone or nonhormone medicine13	When they disrupt sleep, work or daily life13
Low mood, irritability or anxiety	The transition, poor sleep, past depression, stress8	Talk therapy, antidepressants, other options810	Lasting low mood; for thoughts of self-harm, call or text 9887
Joint and muscle aches, fatigue, brain fog	Common in perimenopause7	General habits: activity and a steady sleep routine13	Tell your provider about new or worsening pain and the symptoms that bother you most7
Any bleeding once you’ve gone a full year without a period	Not normal after menopause1	Medical evaluation	Make an appointment right away1

How strong is the evidence?

Approach	Evidence level	What the research shows
Hormone therapy for moderate to severe hot flashes	Strong evidence	FDA-approved use; personal risks vary13
Hormonal IUD for heavy bleeding	Strong evidence	Licensed in Britain to treat heavy periods11
Antidepressants or talk therapy for major depression in perimenopause	Strong evidence	Proven for depression in general; front-line in the 2018 guidelines8
CBT for low mood or anxiety tied to menopause	Promising but early	NICE suggests it; the depression guidelines call the evidence preliminary810
Estrogen for depression in perimenopause	Promising but early	Small trials; not approved for mood8
Combined birth control for perimenopausal hot flashes	Promising but early	“Some evidence,” per the FSRH11
Menopause supplement blends	Not enough evidence	Little evidence of benefit; many hide doses1415
Herbs for perimenopausal depression	Not enough evidence	Too little evidence to recommend8
Estradiol or AMH tests to diagnose perimenopause after 45	Evidence says no, or unsafe	Levels swing; NICE advises against10

Questions readers ask

The bottom line

Perimenopause is a normal transition that can last years and arrive earlier than many women expect. It shows up first on the calendar: cycles that drift, skip, stretch or flood. A daily log tells you and your clinician more than a single hormone test, and birth control still matters until the guideline’s time limits are met.

Fatigue, irritability, aches and low mood are common, and depression in this window is real and treatable. Hormonal and hormone-free options both have evidence behind them. Many products marketed for the transition have little, so ask what each one was tested for before you pay.

Related reading

• Menopause is one day, and the age it arrives shapes your heart and bones
• Real hormone problems have names and tests, which “balance your hormones” claims lack
• Hot flashes aren’t the only thing stealing sleep in menopause
• Heat and pain relievers lead for cramps, while PMDD is a different problem
• Which reproductive symptoms can’t wait an hour, and how to sort the rest

Sources

1. Office on Women’s Health, U.S. Department of Health and Human Services. “Menopause basics.” Updated October 19, 2026. womenshealth.gov
2. National Institute on Aging. “Menopause.” National Institutes of Health, accessed October 2026. nia.nih.gov
3. Harlow SD, Gass M, Hall JE, et al. “Executive Summary of the Stages of Reproductive Aging Workshop + 10: Addressing the Unfinished Agenda of Staging Reproductive Aging.” Journal of Clinical Endocrinology & Metabolism, 2012;97:1159–1168 (University of Illinois Chicago repository record). pubmed.ncbi.nlm.nih.gov
4. MSD Manual Professional Version. “Stages of Menopause” (table adapted from the STRAW+10 executive summary, 2012). Merck & Co., accessed October 2026. msdmanuals.com
5. University of Michigan. “Prolonged and heavy bleeding during menopause is common” (news release on a SWAN study by Paramsothy P, Harlow SD, Greendale GA, et al., BJOG). April 15, 2014. news.umich.edu
6. The Menopause Society. “International Differences Exist in Knowledge Gaps and Most Common Perimenopause Symptoms” (news release on a Flo app survey published in Menopause). January 2026. menopause.org
7. Office on Women’s Health, U.S. Department of Health and Human Services. “Menopause symptoms and relief.” Updated October 19, 2026. womenshealth.gov
8. Maki PM, Kornstein SG, Joffe H, et al. “Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations.” Journal of Women’s Health and Menopause, 2018 (copy hosted by the Australasian Menopause Society). pubmed.ncbi.nlm.nih.gov
9. Centers for Disease Control and Prevention. “When Contraceptive Protection Is No Longer Needed.” U.S. Selected Practice Recommendations for Contraceptive Use, 2024, published November 19, 2024. cdc.gov
10. National Institute for Health and Care Excellence. “Menopause: identification and management” (NG23), Recommendations and “Rationale and impact” chapters, including the 2024 update. nice.org.uk and nice.org.uk
11. Faculty of Sexual & Reproductive Healthcare. “FSRH Guideline: Contraception for Women Aged Over 40 Years.” August 2017, amended May 2025. cosrh.org
12. Office on Women’s Health, U.S. Department of Health and Human Services. “Period problems.” Updated September 26, 2025. womenshealth.gov
13. Office on Women’s Health, U.S. Department of Health and Human Services. “Menopause treatment.” Updated October 19, 2026. womenshealth.gov
14. Eubanks AA, Shvartsman K. “Social Media and Supplements for Menopausal Symptoms: A Content Analysis.” BJOG, 2026;133(10):1885–1892. pmc.ncbi.nlm.nih.gov
15. University College London. “Calls for better research into menopause supplements” (news release on Sullivan P, Harper J, et al., Climacteric). September 11, 2026. ucl.ac.uk